256 related articles for article (PubMed ID: 16404421)
1. mTOR signaling: implications for cancer and anticancer therapy.
Petroulakis E; Mamane Y; Le Bacquer O; Shahbazian D; Sonenberg N
Br J Cancer; 2006 Jan; 94(2):195-9. PubMed ID: 16404421
[TBL] [Abstract][Full Text] [Related]
2. mTOR signaling: implications for cancer and anticancer therapy.
Petroulakis E; Mamane Y; Le Bacquer O; Shahbazian D; Sonenberg N
Br J Cancer; 2007; 96 Suppl():R11-5. PubMed ID: 17393579
[TBL] [Abstract][Full Text] [Related]
3. Hepatitis C virus NS5A binds to the mRNA cap-binding eukaryotic translation initiation 4F (eIF4F) complex and up-regulates host translation initiation machinery through eIF4E-binding protein 1 inactivation.
George A; Panda S; Kudmulwar D; Chhatbar SP; Nayak SC; Krishnan HH
J Biol Chem; 2012 Feb; 287(7):5042-58. PubMed ID: 22184107
[TBL] [Abstract][Full Text] [Related]
4. Cellular stress in xenopus kidney cells enhances the phosphorylation of eukaryotic translation initiation factor (eIF)4E and the association of eIF4F with poly(A)-binding protein.
Fraser CS; Pain VM; Morley SJ
Biochem J; 1999 Sep; 342 Pt 3(Pt 3):519-26. PubMed ID: 10477262
[TBL] [Abstract][Full Text] [Related]
5. Steroid and oxygen effects on eIF4F complex, mTOR, and ENaC translation in fetal lung epithelia.
Otulakowski G; Duan W; Gandhi S; O'brodovich H
Am J Respir Cell Mol Biol; 2007 Oct; 37(4):457-66. PubMed ID: 17556672
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of mammalian target of rapamycin induces phosphatidylinositol 3-kinase-dependent and Mnk-mediated eukaryotic translation initiation factor 4E phosphorylation.
Wang X; Yue P; Chan CB; Ye K; Ueda T; Watanabe-Fukunaga R; Fukunaga R; Fu H; Khuri FR; Sun SY
Mol Cell Biol; 2007 Nov; 27(21):7405-13. PubMed ID: 17724079
[TBL] [Abstract][Full Text] [Related]
7. Reversing drug resistance in vivo.
Wendel HG; Lowe SW
Cell Cycle; 2004 Jul; 3(7):847-9. PubMed ID: 15190216
[TBL] [Abstract][Full Text] [Related]
8. Translation initiation complex eIF4F is a therapeutic target for dual mTOR kinase inhibitors in non-Hodgkin lymphoma.
Demosthenous C; Han JJ; Stenson MJ; Maurer MJ; Wellik LE; Link B; Hege K; Dogan A; Sotomayor E; Witzig T; Gupta M
Oncotarget; 2015 Apr; 6(11):9488-501. PubMed ID: 25839159
[TBL] [Abstract][Full Text] [Related]
9. eIF4F is a nexus of resistance to anti-BRAF and anti-MEK cancer therapies.
Boussemart L; Malka-Mahieu H; Girault I; Allard D; Hemmingsson O; Tomasic G; Thomas M; Basmadjian C; Ribeiro N; Thuaud F; Mateus C; Routier E; Kamsu-Kom N; Agoussi S; Eggermont AM; Désaubry L; Robert C; Vagner S
Nature; 2014 Sep; 513(7516):105-9. PubMed ID: 25079330
[TBL] [Abstract][Full Text] [Related]
10. Many roads from mTOR to eIF4F.
Thoreen CC
Biochem Soc Trans; 2013 Aug; 41(4):913-6. PubMed ID: 23863155
[TBL] [Abstract][Full Text] [Related]
11. Meal feeding enhances formation of eIF4F in skeletal muscle: role of increased eIF4E availability and eIF4G phosphorylation.
Vary TC; Lynch CJ
Am J Physiol Endocrinol Metab; 2006 Apr; 290(4):E631-42. PubMed ID: 16263769
[TBL] [Abstract][Full Text] [Related]
12. mTOR controls cell cycle progression through its cell growth effectors S6K1 and 4E-BP1/eukaryotic translation initiation factor 4E.
Fingar DC; Richardson CJ; Tee AR; Cheatham L; Tsou C; Blenis J
Mol Cell Biol; 2004 Jan; 24(1):200-16. PubMed ID: 14673156
[TBL] [Abstract][Full Text] [Related]
13. Enhance tumor radiosensitivity by intracellular delivery of eukaryotic translation initiation factor 4E binding proteins.
Tian S; Li XL; Shi M; Yao YQ; Li LW; Xin XY
Med Hypotheses; 2011 Feb; 76(2):246-8. PubMed ID: 21050669
[TBL] [Abstract][Full Text] [Related]
14. Manipulation of the host translation initiation complex eIF4F by DNA viruses.
Walsh D
Biochem Soc Trans; 2010 Dec; 38(6):1511-6. PubMed ID: 21118117
[TBL] [Abstract][Full Text] [Related]
15. Survival signalling by Akt and eIF4E in oncogenesis and cancer therapy.
Wendel HG; De Stanchina E; Fridman JS; Malina A; Ray S; Kogan S; Cordon-Cardo C; Pelletier J; Lowe SW
Nature; 2004 Mar; 428(6980):332-7. PubMed ID: 15029198
[TBL] [Abstract][Full Text] [Related]
16. Distinct signaling events downstream of mTOR cooperate to mediate the effects of amino acids and insulin on initiation factor 4E-binding proteins.
Wang X; Beugnet A; Murakami M; Yamanaka S; Proud CG
Mol Cell Biol; 2005 Apr; 25(7):2558-72. PubMed ID: 15767663
[TBL] [Abstract][Full Text] [Related]
17. Phosphorylation of eIF4E by MNKs supports protein synthesis, cell cycle progression and proliferation in prostate cancer cells.
Bianchini A; Loiarro M; Bielli P; Busà R; Paronetto MP; Loreni F; Geremia R; Sette C
Carcinogenesis; 2008 Dec; 29(12):2279-88. PubMed ID: 18809972
[TBL] [Abstract][Full Text] [Related]
18. Overexpressed eIF4E is functionally active in surgical margins of head and neck cancer patients via activation of the Akt/mammalian target of rapamycin pathway.
Nathan CO; Amirghahari N; Abreo F; Rong X; Caldito G; Jones ML; Zhou H; Smith M; Kimberly D; Glass J
Clin Cancer Res; 2004 Sep; 10(17):5820-7. PubMed ID: 15355912
[TBL] [Abstract][Full Text] [Related]
19. Vesicular stomatitis virus infection alters the eIF4F translation initiation complex and causes dephosphorylation of the eIF4E binding protein 4E-BP1.
Connor JH; Lyles DS
J Virol; 2002 Oct; 76(20):10177-87. PubMed ID: 12239292
[TBL] [Abstract][Full Text] [Related]
20. N-acetyl-cysteine abolishes hydrogen peroxide-induced modification of eukaryotic initiation factor 4F activity via distinct signalling pathways.
O'Loghlen A; Pérez-Morgado MI; Salinas M; Martín ME
Cell Signal; 2006 Jan; 18(1):21-31. PubMed ID: 15907373
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
